Fundraising Fox

Dennis Wahr M.D.

President & CEO at Nuvaira

Minneapolis, Minnesota, United States

Find your path to Dennis

57 people in our graph share verified history with Dennis — schools, employers, funds. One of them is your warm intro.

Webb GeorgeunlockedDennis: together at Nuvaira (2025–2026)
×6Dennis: together at Nuvaira
×3Dennis: together at University of California, San Francisco - School of Medicine
×2Dennis: together at Albion College

About

Dennis Wahr, M.D. has served as CEO of Nuvaira, Inc., a venture capital-backed company developing targeted lung denervation technology for COPD treatment, since September 2012. He previously co-founded and led Lutonix (acquired by CR Bard in 2011) and Velocimed (acquired by St. Jude Medical in 2005), and spent two years as a Managing Director at RiverVest Ventures. A board-certified interventional cardiologist, Wahr has served on the boards of several medical device companies, including Accumetrics, IDev, Velocimed, and Lutonix, and currently chairs the board of Intact Vascular.

President & CEO at Nuvaira

Intro paths

In turn, Dennis can intro founders to Nuvaira's investors below.

Co-founders at Nuvaira

MM
SDSteve Dimmer
Steve DimmerFounder

President & CEO at Nuvaira

Intro paths

In turn, Dennis can intro founders to Nuvaira's investors below.

Co-founders at Nuvaira

MM
SDSteve Dimmer
Steve DimmerFounder

Experience

  1. NUVAIRA, Inc.CEOcurrent2012 — present
  2. Intact VascularChairman Of The Board2012 — 2020Greater Philadelphia Area
  3. LutonixCEO2007 — 2011
  4. VelocimedCEO2001 — 2005

Skills & more

Commercialization11Medical Devices26Product Development8Product Launch13Start-ups10Biotechnology2Clinical Trials8Cross-functional Team Leadership5Entrepreneurship3FDA6Market Development5Mergers1
+4 moreVenture CapitalMergers & AcquisitionsManagementStrategic Planning

From Dennis's professional profile.

Frequently asked questions

Who is Dennis Wahr M.D.?
Dennis Wahr, M.D. has served as CEO of Nuvaira, Inc., a venture capital-backed company developing targeted lung denervation technology for COPD treatment, since September 2012. He previously co-founded and led Lutonix (acquired by CR Bard in 2011) and Velocimed (acquired by St. Jude Medical in 2005), and spent two years as a Managing Director at RiverVest Ventures. A board-certified interventional cardiologist, Wahr has served on the boards of several medical device companies, including Accumetrics, IDev, Velocimed, and Lutonix, and currently chairs the board of Intact Vascular.
Where does Dennis Wahr M.D. work?
Dennis Wahr M.D. is President & CEO at Nuvaira and President & CEO at Nuvaira.
Where did Dennis Wahr M.D. go to school?
Dennis Wahr M.D. studied at Albion College (Bachelor of Arts - BA); University of California, San Francisco - School of Medicine (Cardiology Fellowship); University of Michigan.

Same school

Shared employers